Anatara Lifesciences
-
Market
Anatara Lifesciences' GaRP-IBS Trial and the Battle Against IBS in Australia
In Australia, the prevalence of Irritable Bowel Syndrome (IBS) is not just a health concern but also a significant economic…
Read More »